Catheter Precision (VTAK) Net Equity Issued and Repurchased (2017 - 2026)

Catheter Precision (VTAK) has 7 years of Net Equity Issued and Repurchased data on file, last reported at $3.7 million in Q1 2026.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $3.7 million in Q1 2026; TTM through Mar 2026 was $4.9 million, a 143.52% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased for Q1 2026 stood at $3.7 million, up from -$2.6 million in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for VTAK reached as high as $11.5 million in Q1 2023 and fell as low as -$11.3 million in Q4 2023.
• Historically, Net Equity Issued and Repurchased has averaged $1.9 million across 4 years, with a median of $1.9 million in 2025.
• On a YoY basis, Net Equity Issued and Repurchased climbed as much as 18.56% in 2023 and fell as far as 18.56% in 2023.
• Year by year, Net Equity Issued and Repurchased stood at $400000.0 in 2022, then sank by 2915.5% to -$11.3 million in 2023, then surged by 77.14% to -$2.6 million in 2025, then jumped by 244.95% to $3.7 million in 2026.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $3.7 million in Q1 2026, -$2.6 million in Q4 2025, and $2.2 million in Q3 2025.